Literature DB >> 10449786

Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types.

A L Boerger1, S Snitkovsky, J A Young.   

Abstract

Successful targeting methods represent a major hurdle to the use of retroviral vectors in cell-specific gene-delivery applications. We recently described an approach for retroviral targeting with a retroviral receptor-ligand bridge protein that was bound to the cognate cell-surface ligand receptors before viral challenge. We now report a significant improvement made to this viral targeting method by using a related bridge protein, designated TVB-EGF, comprised of the extracellular domain of the TVB receptor for subgroup B avian leukosis virus fused to epidermal growth factor (EGF). The most important activity of TVB-EGF was that it allowed specific viral entry when preloaded onto virions. Furthermore, virions preloaded with TVB-EGF were thermostable and could be produced directly from virus- packaging cells. These data suggest an approach for targeting retroviral vectors to specific cell types by using virions preloaded with a retroviral receptor-ligand bridge protein and indicate that these types of bridge proteins may be useful reagents for studying the normal mechanism of retroviral entry.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449786      PMCID: PMC22302          DOI: 10.1073/pnas.96.17.9867

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.

Authors:  P Roux; P Jeanteur; M Piechaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Packaging system for rapid production of murine leukemia virus vectors with variable tropism.

Authors:  N R Landau; D R Littman
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker.

Authors:  M Etienne-Julan; P Roux; S Carillo; P Jeanteur; M Piechaczyk
Journal:  J Gen Virol       Date:  1992-12       Impact factor: 3.891

4.  Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies.

Authors:  J R Glenney; W S Chen; C S Lazar; G M Walton; L M Zokas; M G Rosenfeld; G N Gill
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

5.  Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor.

Authors:  D F Stern; D L Hare; M A Cecchini; R A Weinberg
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

6.  Retroviral vectors displaying functional antibody fragments.

Authors:  S J Russell; R E Hawkins; G Winter
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

7.  Tissue-specific targeting of retroviral vectors through ligand-receptor interactions.

Authors:  N Kasahara; A M Dozy; Y W Kan
Journal:  Science       Date:  1994-11-25       Impact factor: 47.728

8.  Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors.

Authors:  S Valsesia-Wittmann; A Drynda; G Deléage; M Aumailley; J M Heard; O Danos; G Verdier; F L Cosset
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity.

Authors:  H Neda; C H Wu; G Y Wu
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

10.  Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies.

Authors:  A Jiang; T H Chu; F Nocken; K Cichutek; R Dornburg
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  36 in total

1.  Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus.

Authors:  A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Antibody-directed targeting of retroviral vectors via cell surface antigens.

Authors:  K Morizono; G Bristol; Y M Xie ; S K Kung; I S Chen
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  A fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses.

Authors:  Daniel J Knauss; John A T Young
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor.

Authors:  S Snitkovsky; T M Niederman; B S Carter; R C Mulligan; J A Young
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Recombinant measles viruses efficiently entering cells through targeted receptors.

Authors:  U Schneider; F Bullough; S Vongpunsawad; S J Russell; R Cattaneo
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion.

Authors:  Eric R Kinzler; Teresa Compton
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Avian sarcoma and leukosis virus cytopathic effect in the absence of TVB death domain signaling.

Authors:  Sara Klucking; Asha S Collins; John A T Young
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

8.  Targeting lentiviral vectors to specific cell types in vivo.

Authors:  Lili Yang; Leslie Bailey; David Baltimore; Pin Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

9.  Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons.

Authors:  Ian R Wickersham; David C Lyon; Richard J O Barnard; Takuma Mori; Stefan Finke; Karl-Klaus Conzelmann; John A T Young; Edward M Callaway
Journal:  Neuron       Date:  2007-03-01       Impact factor: 17.173

Review 10.  Lentiviral vectors for immune cells targeting.

Authors:  Steven Froelich; April Tai; Pin Wang
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.